UCB strengthens ICT department to foster its transformation into a global patient centric biopharma leader
Brussels, 19 July 2010 – UCB is launching a recruitment campaign aimed at reinforcing its IT teams with international positions mainly based in Belgium. The biopharmaceuticals company intends to gradually hire around 40 ICT staff, senior or junior, technology –or business oriented, to execute vital IT functions using its own resources. Some of these functions were previously provided by outside suppliers and are now selectively being internalized. This will not only contribute to increase UCB efficiency but will also leverage capability to use technology in developing treatments for patients.
“The IT department has a vital place in UCB’s business strategy,” says Herman De Prins, Chief Information Officer at UCB. “We don’t just build infrastructure for everyday operations: we provide and supply solutions that actively help us to develop the best treatments for the patient. Our IT strategy is built on three cornerstones: improving customer satisfaction, rationalising processes and systems and creating added value.”
UCB aims to improve its ICT-capability in research and development, infrastructure, corporate functions, architecture, processes and SAP. All job vacancies can be found at www.itjobsatucb.com.
To support this recruitment campaign, UCB will be making use of various tools and social media. A micro-site, a Facebook fan page, a YouTube channel, a LinkedIn group and a Twitter account will enable web-surfers to find out more about the jobs they’re looking for, about UCB's corporate culture, and to share the information with their networks. UCB can be found at:
Notes to Editors:
UCB (Brussels, Belgium) (www.ucb.com) is a biopharmaceutical company dedicated to research, development and marketing of innovative medications, focused on disorders of the central nervous system and immunology. UCB employs over 9,000 people spread over 40 countries, and posted up a EUR 3.1 billion turnover in 2009. UCB is quoted on the Brussels Euronext market (symbol: UCB).
This press release includes prospective statements predicated on the management’s current plans, estimates and beliefs. Those prospective statements entail risks and uncertainties that may produce actual results significantly at variance from those assumed in the prospective statements included in this press release. Among such unknown factors liable to result in such difference are: changes that affect the general economic situation, the sphere of operations and competition, the effects of future court rulings, changes to official regulations, exchange-rate fluctuations, also staff recruitment and retention.
Stay up-to-date on the latest news and information from UCB